Mar 28, 2007
Notice
Kringle Pharma to initiate a phase I clinical trial of recombinant human HGF for acute renal failure cooperatively with The Rogosin Institute.
Kringle Pharma to initiate a phase I clinical trial of recombinant human HGF for acute renal failure cooperatively with The Rogosin Institute.
